Home >
Medicine Info >
Zepdon 400 mg Tablet
Loading interface...

Zepdon 400 mg Tablet

Manufactured byCipla Ltd.
ContainsRaltegravir
Description
Zepdon 400 mg Tablet is an antiviral medicine which is used alone or in combination with other medicines to treat human immunodeficiency virus (HIV) infection. This medicine is not a cure for HIV. It only prevents the virus from multiplying in your body. It should be used with caution in elderly patients.
QUICK LINKS:
Side effectsConcernsUsage

Substitutes

List of substitutes for Zepdon 400 mg Tablet

Isentress 400 mg Tablet
Msd Pharmaceuticals Pvt. Ltd.

Side effects

Major & minor side effects for Zepdon 400 mg Tablet

  • Blood in urine
  • Fast heartbeat
  • Fever
  • Hoarseness
  • Irritation
  • Tightness of chest
  • Loss of appetite
  • Nausea and Vomiting
  • Redness of skin
  • Upper right stomach pain

Uses of Zepdon 400 mg Tablet

What is it prescribed for?

  • HIV infection
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required for this medicine to show its effect is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is recommended for use in breastfeeding women only in life-threatening conditions. The risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is recommended for use in breastfeeding women only in life-threatening conditions. The risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
General warnings

Drug rash with eosinophilia and systemic symptoms syndrome

This medicine should be used with caution since it may cause a Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome. Appropriate corrective measures may need to be taken or therapy may need to be discontinued based on the clinical condition of the patient.

Myopathy

This medicine should be used with caution in patients with a known history of myopathy or increase in serum creatine kinase levels due to the increased risk of worsening of the patient's condition.

Autoimmune disorders

This medicine should be used with caution in patients with a known history of autoimmune disorders due to the increased risk of worsening of the patient's condition.

Missed Dose

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Rifampicin

Aluminium Hydroxide

Magnesium Hydroxide

Magnesium oxide

Disease interactions

Hepatic impairment

Zepdon 400 mg Tablet should be used with caution in patients with a known history of hepatic impairment. Close monitoring of liver function may be necessary based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Zepdon 400 mg Tablet exactly as instructed by the doctor. Do not take in larger or smaller quantities than recommended. Ensure that proper hygiene measures are adopted. Complete the course of treatment to prevent the spread of the infection.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
It works by stopping the human immunodeficiency virus (HIV) from multiplying. This helps in reducing the chances of development of acquired immunodeficiency syndrome (AIDS) and other HIV-related illnesses.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Integrase strand transfer inhibitor

Schedule

Schedule H

DailyMed - ISENTRESS - raltegravir tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 28 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbd3e1af-81f3-44f6-8e45-652deab7a508#i4i_microbiology_id_bd0b8009-01f3-49b6-bf82-615647a6f38a

EMC [Internet]. 2017 [cited 28 August 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/20484

Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 28 August 2017]. Available from:

http://www.tga.gov.au/prescribing-medicines-pregnancy-database

Raltegravir - DrugBank [Internet]. Drugbank.ca. 2017 [cited 28 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB06817

Raltegravir: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 28 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a608004.html

Toxnet [Internet]. Toxnet.nlm.nih.gov. 2017 [cited 28 August 2017]. Available from:

https://toxnet.nlm.nih.gov/cgi-bin/sis/search2
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 4 Sep 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.